Copyright
©The Author(s) 2025.
World J Gastroenterol. Apr 28, 2025; 31(16): 104758
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.104758
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.104758
Table 3 Stratified analysis
Conditional independence tests (χ2, P value) | OR parity test (P value) | Estimated combined OR (95%CI) | |
Age (≤ 51, > 51), year | 26.588, P = 0.000 | 0.208 | 10.850 (3.726-31.594) |
Fever | 19.673, P = 0.000 | 0.635 | 9.254 (2.998-28.569) |
CMV positivity | 21.170, P = 0.000 | 0.712 | 10.669 (3.361-33.867) |
Fungal infection | 30.291, P = 0.000 | 0.437 | 14.969 (4.875-45.962) |
Hemoglobin (≤ 113, >113) g/L | 22.047, P = 0.000 | 0.708 | 12.459 (3.726-41.661) |
CRP (≤ 11.74, > 11.74) mg/L | 16.495, P = 0.000 | 0.339 | 10.979 (3.071-39.245) |
ESR (≤ 27, > 27) mm/hour | 28.514, P = 0.000 | 0.369 | 12.056 (4.070-35.715) |
Albumin (≤ 35.2, > 35.2) g/L | 20.065, P = 0.000 | 0.598 | 9.897 (3.119-31.409) |
Prealbumin (≤ 163, >163) g/L | 28.164, P = 0.000 | 0.127 | 10.992 (3.822-31.612) |
Treatment with ≥ 3 types of immunosuppressive drugs before admission | 42.469, P = 0.000 | 0.825 | 25.583 (7.836-83.531) |
Antibiotic therapy with third-generation cephalosporins or more advanced antibiotics during admission | 23.298, P = 0.000 | 0.087 | 12.659 (4.035-39.719) |
- Citation: Zhang H, Gu X, He W, Zhao SL, Cao ZJ. Epstein-Barr virus infection is an independent risk factor for surgery in patients with moderate-to-severe ulcerative colitis. World J Gastroenterol 2025; 31(16): 104758
- URL: https://www.wjgnet.com/1007-9327/full/v31/i16/104758.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i16.104758